Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window

 Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and Company''s code on prohibition of insider trading, the 'Trading Window' for dealing in the securities of the Company shall remain closed for all Designated Persons and their immediate relatives from Sunday, 01 January 2023 till the completion of 48 hours after the Unaudited Financial Results of the Company for the quarter and nine months ending 31 December 2022 become Generally Available Information. Accordingly, all Designated Persons and their immediate relatives of the Company have been advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window.
29-12-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
14-12-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
24-11-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22 November 2021, for the half year ended 30 September 2022. The above information shall be made available on the website of the Company at www.tatvachintan.com.
16-11-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
14-11-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended 30 September 2022, issued by ICICI Bank Limited, appointed to monitor the utilization of proceeds of an Initial Public Offering ('IPO') of the Company. The above information shall be made available on the website of the Company at www.tatvachintan.com.
10-11-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Statement Of Deviation / Variation In Utilization Of Funds Raised Through IPO

 Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed herewith statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended 30 September 2022 in the prescribed format. The same will be filed in XBRL mode separately. We confirm that, as at 30 September 2022, there has not been any deviation(s) or variation(s) in the utilization of net proceeds of IPO as mentioned in the objects stated in the Prospectus dated 22 July 2021. Report issued by Monitoring agency report is being separately filed with the exchange. The above information shall be made available on the website of the Company at www.tatvachintan.com.
10-11-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed herewith the transcript of the earnings call held on 04 November 2022 post announcement of financial results of the Company for the quarter and half year ended 30 September 2022. The above information shall be made available on Company's website of at www.tatvachintan.com.
08-11-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing herewith copies of newspaper publication of extract of financial results of the Company for the quarter and half year ended 30 September 2022, published in Financial Express (English edition) and Vadodara Samachar (Gujarati edition) on 05 November 2022. The above information shall be made available on the website of the Company at www.tatvachintan.com.
05-11-2022
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Earnings Call Recording

 Pursuant to Regulation 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we hereby inform the exchanges that the recording of the Earnings Call held on Friday, 04 November 2022 at 05:00 p.m. IST is available on the website of the Company. The recording can be accessed from the following link: https://www.tatvachintan.com/wp-content/uploads/2022/11/ICI3420221104143915.mp3 The above information is available on the website of the Company at www.tatvachintan.com.
04-11-2022
Next Page
Close

Let's Open Free Demat Account